Practical recommendations were consolidated into a summary table and accompanying educational infographic for patients
Medicaid spending Medicaid programs cover some GLP-1 drugs to treat obesity in a dozen other states: California, Delaware, Kansas, Massachusetts, Michigan, Minnesota, Mississippi, New Hampshire, Pennsylvania, Rhode Island, Virginia and Wisconsin
Medical professionals recommend choosing FDA-approved treatments and consulting with a qualified healthcare professional to ensure safe and effective results
Nicholls and colleagues outlined a preservation-of-effect framework
What This Means for Patients After several years of real-world use and growing scientific study, evidence suggests that GLP-1 medications may support mental health in addition to weight loss